Clinical Trials Browser

INDUSTRY × Sarcoma × envafolimab × Clear all

NCT04480502 2024-05-17

ENVASARC

Phase 2 Unknown

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma